Name: Burning Rock Biotech Limited (BNR) Financial Statements
Creator: FinSpry

Burning Rock Biotech Income Statement Analysis

Revenue, earnings, and profit margins in billions CNY

Scale:

Scroll to see more

Burning Rock Biotech Limited income statement - Annual data in billions CNY
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.52	0.54	0.56	0.51	0.43
Cost of Revenue	0.15	0.17	0.18	-0.22	0.12
Gross Profit	0.36	0.36	0.38	0.73	0.31
Operating Expenses
Research & Development	0.23	0.35	0.42	0.37	0.26
Selling, General & Administrative	0.45	0.69	0.94	0.79	0.46
Operating Expenses	0.68	1.03	1.36	1.16	0.73
Operating Income	-0.32	-0.67	-0.98	-0.43	-0.41
Other Income/Expense
Interest Income	0.01	0.02	0.01	0.00	0.01
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	0.00	0.00	0.00	0.00	0.00
Income
Income Before Tax	-0.34	-0.65	-0.97	-0.43	-0.41
Income Tax Expense	0.01	0.00	0.00	0.00	0.00
Net Income	-0.35	-0.65	-0.97	-0.43	-0.41
Net Income - Continuous Operations	-0.35	-0.65	-0.97	-0.80	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-0.27	-0.54	-0.86	-0.43	-0.37
EBIT	-0.32	-0.67	-0.98	-0.43	-0.41
Depreciation & Amortization	0.05	0.13	0.12	-0.04	0.03
Earnings Per Share
Basic EPS	-34.00	-64.00	-93.00	-76.00	-7.00
Diluted EPS	-34.00	-64.00	-93.00	-76.00	-7.00
Basic Shares Outstanding	0.01	0.01	0.01	0.01	0.07
Diluted Shares Outstanding	0.01	0.01	0.01	0.01	0.07